Robert Tohn

NKT Cells Stimulated by Long Fatty Acyl Chain Sulfatides Significantly Reduces the Incidence of Type 1 Diabetes in Nonobese Diabetic Mice

Lakshmimathy Subramanian, Hartley Blumenfeld, Robert Tohn et al. · PLoS ONE · 2012 · 53 citations · Full text

Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice

Hartley Blumenfeld, Robert Tohn, S. M. Mansour Haeryfar et al. · Clinical & Experimental Immunology · 2011 · 23 citations · Full text

Engineering, T-regulatory Cell, Immunology +27

Characterization of Cross-Reactive CD8 ⁺ T-Cell Recognition of HLA-A2-Restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) Epitopes in Individuals Infected with Human Immunodeficiency and Hepatitis C Viruses

Bahareh Vali, Robert Tohn, Michael R. Cohen et al. · Journal of Virology · 2010 · 23 citations · Full text

Immunodeficiencies, Immunology, Immunodominance +21

An α-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes

Dalam Ly, Robert Tohn, Bent Rubin et al. · Clinical & Experimental Immunology · 2009 · 16 citations · Full text

Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes

Robert Tohn, Hartley Blumenfeld, S. M. Mansour Haeryfar et al. · Clinical & Experimental Immunology · 2011 · 14 citations · Full text